Texas Instruments Incorporated (TXN)

Environment story

Texas Instruments' 10-K risk factors reference climate change only as a general operational risk (e.g., natural-disaster and supply disruption exposure) and do not disclose Scope 3 emissions trends or a net-zero target year. Under the deterministic rubric, 15 points were deducted for undisclosed/unconfirmed Scope 3 trend data and 15 points for the absence of a disclosed net-zero target year before 2045. No specific toxic-waste or water-consumption controversy was identified in the reviewed filings, so no severity deduction was applied. Capital expenditure on new 300mm fabs (Sherman, TX; Lehi, UT) funded partly via CHIPS Act incentives represents physical manufacturing infrastructure investment, but the filings do not verify this capacity expansion as decarbonization-specific, so no credit was added. This is a research summary only and does not constitute investment advice.

Social story

No union-suppression activity, major strikes, or documented supply-chain human-rights violations were identified in the reviewed filings, and no CEO-to-median-worker pay ratio figure was disclosed in the provided excerpt, so no deduction was applied for that criterion. Board/leadership gender representation (approximately 4 of 12 director nominees are women, ~33%) does not fall under the 30% threshold that would trigger a deduction. A stockholder proposal referenced October 2025 media reports of concurrent layoffs and H-1B hiring, which is noted as a labor-related controversy but did not meet the rubric's specific strike/union-suppression deduction criteria. This is a research summary only and does not constitute investment advice.

Governance story

TXN maintains a single class of common stock with one vote per share (no dual-class structure), and board independence stands at 11 of 12 directors (~91.7%), both above the rubric's penalty thresholds, resulting in zero deductions for share structure or board independence. No lobbying expenditure data targeting climate or consumer-protection deregulation was disclosed in reviewed filings. A August 2025 patent infringement lawsuit and a September 2025 Chinese Ministry of Commerce anti-dumping investigation were disclosed as pending legal/regulatory matters; neither was characterized in the filings as antitrust, consumer-safety, or financial-fraud proceedings meeting the rubric's specific deduction criteria, so no points were deducted. This is a research summary only and does not constitute investment advice.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Texas Instruments Incorporated. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Texas Instruments Incorporated in the app for interactive charts and portfolio building.

More in Technology